SCHEMBL7664382

SCHEMBL7664382

CCCc1cnc(-c2ccccc2Oc2ccc(Cl)cc2Cl)cn1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC6A2 P23975 5/20 0.43
▸ SLC6A4 P31645 4/20 0.43
▸ SLC6A3 Q01959 4/20 0.43
▸ CHRM1 P11229 1/20 0.40
▸ MAPT P10636 2/20 0.39
▸ PLA2G1B P04054 1/20 0.39
▸ ATG4B Q9Y4P1 1/20 0.39
▸ NPC1 O15118 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ TTR P02766 2/20 0.37
▸ HPGD P15428 2/20 0.37
▸ NR1I2 O75469 1/20 0.37
▸ LMNA P02545 1/20 0.37
▸ PGR P06401 1/20 0.37
▸ HSP90AA1 P07900 1/20 0.37
▸ ADORA3 P0DMS8 1/20 0.37
▸ HSPA5 P11021 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7668578 0.82 L3MBTL1 (0.36) MAPTNPC1RAB9ANPSR1L3MBTL1
SCHEMBL7664372 0.81 PLAU (0.41) MAPTNPC1RAB9ANPSR1L3MBTL1
SCHEMBL7667019 0.80 TRPA1 (0.41) L3MBTL1SREBF2
SCHEMBL7673906 0.77 KEAP1 (0.39) SLC6A2SLC6A4SLC6A3MAPTNPC1
SCHEMBL7666933 0.74 CYP11B1 (0.42) TDP1LMNASREBF2
SCHEMBL7664751 0.71 HTR2A (0.40) SLC6A4L3MBTL1
SCHEMBL7666782 0.69 NPC1 (0.38) SLC6A2SLC6A4SLC6A3NPC1RAB9A
SCHEMBL7670839 0.69 CYP11B1 (0.41) MAPTNPC1RAB9AHPGDTSHR
SCHEMBL7664066 0.67 BCL2L2 (0.37) SLC6A2SLC6A4SLC6A3MAPTNPSR1
SCHEMBL10462078 0.67 PDE5A (0.41) SREBF2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6458813-B1 2-CYCLOHEXYLOXY-5-(2-CHLOROPHENYLCARBONYLAMINO)PYRIDINE, FOR EXAMPLE; TREATING INFLAMMATION, PAIN, DIABETES, CANCER AMGEN INC. 2002-10-01 — — US disclosed
US-6333341-B1 TUMOR NECROSIS FACTOR, ANTIINFLAMMATORY AGENTS AND ANALGESICS AMGEN INC. 2001-12-25 — — US disclosed
US-6184237-B1 Substituted pyridine compounds and methods of use AMGEN INC. 2001-02-06 — — US disclosed
Send feedback